ClearPoint Neuro Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.84
Dividend & YieldN/A$ (N/A)
Beta 1.11
Market capitalization 223.45M
Operating cash flow -16.65M
ESG Scores unknown

Company description

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Sector: Healthcare - Industry: Medical Devices

Financial Ratios
Quick Ratio11.98
Working Capital-0.25
Return On Equity-0.3
Debt To Equity0.2
Fixed Asset Ratio0
Fixed Interest Cover-13.75

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities -189.54k 2.03M -896k 1.45M
Total Cashflows From Investing Activities -63.49k -160k -482k -168k
Net Borrowings -2M -2.14M 22.32M
Total Cash From Financing Activities -1.49M 5.61M 22.69M 46.88M
Change To Operating Activities -31.85k -238k -950k -762k
Issuance Of Stock 505.38k 7.82M 376k 47.47M
Net Income -6.16M -5.54M -6.78M -14.41M
Change In Cash -6.19M 2.6M 14.4M 34.01M
Effect Of Exchange Rate
Total Cash From Operating Activities -4.63M -2.85M -7.81M -12.7M
Depreciation 109.44k 251k 550k 692k
Change To Account Receivables -284.48k 144k -818k -658k
Other Cashflows From Financing Activities -75k -75k
Change To Netincome 1.24M 799k 224k 2.6M
Capital Expenditures -63.49k -10k -41k -168k

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 2.31M 2.81M 4.69M 8.98M
Income Before Tax -6.16M -5.54M -6.78M -14.41M
Net Income -6.16M -5.54M -6.78M -14.41M
Selling General Administrative 7.86M 9.06M 10.65M 15.68M
Gross Profit 4.92M 7.28M 9.12M 11.29M
Ebit -5.25M -4.59M -6.22M -13.37M
Operating Income -5.25M -4.59M -6.22M -13.37M
Interest Expense -980.38k -955k -1.44M -973k
Income Tax Expense
Total Revenue 7.35M 11.22M 12.83M 16.3M
Cost Of Revenue 2.43M 3.94M 3.71M 5.01M
Total Other Income ExpenseNet -915.7k -946k -562k -1.04M
Net Income From Continuing Ops -6.16M -5.54M -6.78M -14.41M
Net Income Applicable To Common Shares -6.16M -5.54M -6.78M -14.41M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 6.35M 7.34M 27.14M 16.79M
Total Stockholder Equity 1.51M 4.59M 2.38M 48.79M
Other Current Liabilities 210.77k 1.02M 562k 678k
Total Assets 7.86M 11.93M 29.52M 65.58M
Common Stock 110.18k 152k 170k 237k
Other Current Assets
Retained Earnings -107.2M -112.74M -119.52M -133.93M
Treasury Stock
Cash 3.1M 5.7M 20.1M 54.11M
Total Current Liabilities 1.87M 3.83M 3.2M 4.75M
Other Stockholder Equity
Property, Plant, and Equipment 377.71k 821k 3.06M 2.78M
Total Current Assets 6.65M 10.38M 25.46M 61.89M
Net Tangible Assets 1.51M 4.59M 2.02M 48.52M
Net Receivables 1.23M 1.09M 1.88M 2.34M
Accounts Payable 500.93k 966k 300k 427k


Insider Transactions

Here are the insider transactions of stock shares related to ClearPoint Neuro Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
SABRA MAZINStock Award(Grant) at price 0.00 per share.D2022-10-10Chief Operating Officer46k
FLETCHER R JOHNStock Award(Grant) at price 10.19 per share.D2022-10-03Director1.7k
JOHNSON B KRISTINEStock Award(Grant) at price 10.19 per share.D2022-10-03Director337
GIRIN PASCAL E RStock Award(Grant) at price 10.19 per share.D2022-10-03Director705
RICHARDS TIMOTHY TStock Award(Grant) at price 10.19 per share.D2022-10-03Director1.09k
BURNETT JOSEPH MICHAELSale at price 16.07 per share.D2022-08-15Chief Executive Officer18.87k
FLETCHER R JOHNStock Award(Grant) at price 12.63 per share.D2022-07-01Director1.37k
JOHNSON B KRISTINEStock Award(Grant) at price 12.63 per share.D2022-07-01Director272
GIRIN PASCAL E RStock Award(Grant) at price 12.63 per share.D2022-07-01Director668
RICHARDS TIMOTHY TStock Award(Grant) at price 12.63 per share.D2022-07-01Director883
BURNETT JOSEPH MICHAELStock Award(Grant) at price 0.00 per share.D2022-06-10Chief Executive Officer70.11k
D'ALESSANDRO DANILOStock Award(Grant) at price 0.00 per share.D2022-06-10Chief Financial Officer23.4k
STIGALL L JEREMYStock Award(Grant) at price 0.00 per share.D2022-06-10Officer17.53k
FLETCHER R JOHNStock Award(Grant) at price 0.00 per share.D2022-05-25Director9.27k
JOHNSON B KRISTINEStock Award(Grant) at price 0.00 per share.D2022-05-25Director9.27k
FALLON LYNNETTE CStock Award(Grant) at price 0.00 per share.D2022-05-25Director9.27k
GIRIN PASCAL E RStock Award(Grant) at price 0.00 per share.D2022-05-25Director9.27k
RICHARDS TIMOTHY TStock Award(Grant) at price 0.00 per share.D2022-05-25Director9.27k
KLEIN MATTHEW BStock Award(Grant) at price 0.00 per share.D2022-05-25Director9.27k
LIAU LINDA M. M.D., PH.D.Stock Award(Grant) at price 0.00 per share.D2022-05-25Director9.27k
FLETCHER R JOHNStock Award(Grant) at price 9.96 per share.D2022-04-01Director1.74k
JOHNSON B KRISTINEStock Award(Grant) at price 9.96 per share.D2022-04-01Director345
GIRIN PASCAL E RStock Award(Grant) at price 9.96 per share.D2022-04-01Director847
RICHARDS TIMOTHY TStock Award(Grant) at price 9.96 per share.D2022-04-01Director1.12k
FLETCHER R JOHNStock Award(Grant) at price 11.54 per share.D2021-12-31Director2k
JOHNSON B KRISTINEStock Award(Grant) at price 11.54 per share.D2021-12-31Director595
GIRIN PASCAL E RStock Award(Grant) at price 11.54 per share.D2021-12-31Director730
RICHARDS TIMOTHY TStock Award(Grant) at price 11.54 per share.D2021-12-31Director644
BURNETT JOSEPH MICHAELSale at price 16.88 per share.D2021-11-11Chief Executive Officer10k
LIAU LINDA M. M.D., PH.D.Stock Award(Grant) at price 0.00 per share.D2021-11-02Director3.43k
FLETCHER R JOHNStock Award(Grant) at price 17.92 per share.D2021-10-01Director1.29k
JOHNSON B KRISTINEStock Award(Grant) at price 17.92 per share.D2021-10-01Director383
GIRIN PASCAL E RStock Award(Grant) at price 17.92 per share.D2021-10-01Director470
RICHARDS TIMOTHY TStock Award(Grant) at price 17.92 per share.D2021-10-01Director414
BURNETT JOSEPH MICHAELSale at price 17.98 per share.D2021-09-21Chief Executive Officer9.64k
BURNETT JOSEPH MICHAELStock Award(Grant) at price 0.00 per share.D2021-08-20Chief Executive Officer14.69k
PIFERI PETER GStock Award(Grant) at price 0.00 per share.D2021-08-20Chief Operating Officer2.2k
D'ALESSANDRO DANILOStock Award(Grant) at price 0.00 per share.D2021-08-20Chief Financial Officer5.88k
PIFERI PETER GConversion of Exercise of derivative security at price 3.47 per share.D2021-08-16Chief Operating Officer8.93k
PIFERI PETER GConversion of Exercise of derivative security at price 2.60 - 3.47 per share.D2021-07-23Chief Operating Officer27.61k
FALLON LYNNETTE CStock Award(Grant) at price 0.00 per share.D2021-07-15Director3.59k
FLETCHER R JOHNStock Award(Grant) at price 20.26 per share.D2021-06-30Director771
JOHNSON B KRISTINEStock Award(Grant) at price 20.26 per share.D2021-06-30Director257
GIRIN PASCAL E RStock Award(Grant) at price 20.26 per share.D2021-06-30Director296
RICHARDS TIMOTHY TStock Award(Grant) at price 20.26 per share.D2021-06-30Director291
FLETCHER R JOHNStock Award(Grant) at price 0.00 per share.D2021-06-25Director3k
JOHNSON B KRISTINEStock Award(Grant) at price 0.00 per share.D2021-06-25Director3k
GIRIN PASCAL E RStock Award(Grant) at price 0.00 per share.D2021-06-25Director3k
RICHARDS TIMOTHY TStock Award(Grant) at price 0.00 per share.D2021-06-25Director3k
KLEIN MATTHEW BStock Award(Grant) at price 0.00 per share.D2021-06-25Director3k
BURNETT JOSEPH MICHAELSale at price 18.57 per share.D2021-06-21Chief Executive Officer25k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to ClearPoint Neuro Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on ClearPoint Neuro Inc

Here is the result of two systematic investment strategies applied to ClearPoint Neuro Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on ClearPoint Neuro Inc

The following chart shows the equity curve of the two systematic investment strategies applied to ClearPoint Neuro Inc:

ClearPoint Neuro Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 348.57% on the backtest period.

Performance at glance

Performance

348.57 %

Latent gain

7866.79 $

Invested capital

2256.89 $

Annualized return

83.79 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on ClearPoint Neuro Inc

This is the result of two momentum investment strategies applied to ClearPoint Neuro Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on ClearPoint Neuro Inc

The following chart shows all the entries opened by the momentum investment system on ClearPoint Neuro Inc:

ClearPoint Neuro Inc momentum entries
  • The first momentum investment strategy would give 348.96% of return on ClearPoint Neuro Inc. That represents 16592.86$ of latent gain with 4754.9$ of employed capital.
  • The second momentum investment strategy would give 419.8% of return on ClearPoint Neuro Inc. That represents 11553.14$ of latent gain with 2752.06$ of employed capital.
Performance at glance (1Q Momentum)

Performance

348.96 %

Latent gain

16592.86 $

Invested capital

4754.9 $

Annualized return

115.04 %
Performance at glance (2Q Momentum)

Performance

419.8 %

Latent gain

11553.14 $

Invested capital

2752.06 $

Annualized return

114.08 %

Momentum equity curve on ClearPoint Neuro Inc

The following chart shows the equity curve of the two momentum strategies applied to ClearPoint Neuro Inc:

ClearPoint Neuro Inc momentum equity

Note: the dividends potentially given by ClearPoint Neuro Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on ClearPoint Neuro Inc

The following chart shows the employed capital evolution of the two momentum strategies on ClearPoint Neuro Inc since the beginning:

ClearPoint Neuro Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on ClearPoint Neuro Inc

Buy the dip entry openings on ClearPoint Neuro Inc

ClearPoint Neuro Inc

The performance achieved by the robo-advisor on ClearPoint Neuro Inc is 248.48%. That represents 1255.41$ of latent gain with 505.23$ of employed capital. The following chart shows ClearPoint Neuro Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of ClearPoint Neuro Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

248.48 %

Latent gain

1255.41 $

Invested capital

505.23 $

Annualized return

115.04 %

Equity curve of the strategy applied to ClearPoint Neuro Inc

The following chart shows the result of the investment strategy applied to ClearPoint Neuro Inc:

ClearPoint Neuro Inc

Note: the dividends potentially given by ClearPoint Neuro Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on ClearPoint Neuro Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on ClearPoint Neuro Inc:

ClearPoint Neuro Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on ClearPoint Neuro Inc

In this section, I will compare the three previous investment strategies applied to ClearPoint Neuro Inc.

Equity curve comparison on ClearPoint Neuro Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

ClearPoint Neuro Inc investment strategy comparison

Employed capital comparison on ClearPoint Neuro Inc

ClearPoint Neuro Inc investment comparison

Performance comparison on ClearPoint Neuro Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 348.57% 7866.79$ 2256.89$ 83.79%
Momentum 1 quarter 348.96% 16592.86$ 4754.9$ 89.02%
Momentum 2 quarters 419.8% 11553.14$ 2752.06$ 114.08%
Non-directional 248.48% 1255.41$ 505.23$ 115.04%
Annualized return comparison

Automatic investment

83.79 %

Momentum 1Q

114.08 %

Momentum 2Q

114.08 %

Non-directional

115.04 %

Correlated stocks

Here are the most positively and negatively correlated stocks with ClearPoint Neuro Inc:

Positive correlations

Most correlated stocks this year

  • ClearPoint Neuro Inc

  • Most correlated stocks last 3 months

  • ClearPoint Neuro Inc

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months


    Note: The algorithm computes the probability of correlation between ClearPoint Neuro Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of ClearPoint Neuro Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name ClearPoint Neuro Inc
    Country United States
    City Solana Beach
    Address 120 S. Sierra Avenue
    Phone 888 287 9109
    Website www.clearpointneuro.com
    FullTime employees 80
    Industry Medical Devices
    Sector Healthcare
    Exchange XNAS
    Ticker CLPT
    Market www.nasdaq.com

    ClearPoint Neuro Inc ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown